Company: BCAR
Filing Date: 2025-04-29
Form Type: S-1
Source: 0001829126-25-003006
Chunk: 298

Company: D. Boral ARC Acquisition I Corp.
Filing Date: 2025-04-29
Form: S-1
Chunk 298
---
 tax treaties and the possible effects of changes in U.S. or other tax laws.

<div align='center'>187

Underwriting (CONFLICTS OF INTEREST)</div>

D. Boral Capital is acting as sole book-running
manager and representative of the underwriters of the offering. Subject to the terms and conditions stated in the underwriting
agreement dated the date of this prospectus, each underwriter named below has agreed to purchase, and we have agreed to sell to that
underwriter, the number of units set forth opposite the underwriter’s name. The underwriters may offer and sell units to the
public through one or more of their respective affiliates or other registered broker-dealers or selling agents.

| Underwriters          |     | Number of 
 Units     |            |
| D. Boral Capital, LLC |     |           |            |
|                       |     |           | 25,000,000 |

The underwriting agreement provides that the obligations of the underwriters to purchase the units included in this offering are subject to approval of legal matters by counsel and to other conditions. The underwriters are obligated to purchase all of the units (other than those covered by the over-allotment option described below) if they purchase any of the units.

Pricing of the Offering

We have been advised by the underwriters that they propose to offer the units to the public at the initial offering price set forth on the cover page of this prospectus. If all of the units are not sold at the initial offering price, the representative may change the offering price and other selling terms. The offering of the units by the underwriters is subject to receipt and acceptance and subject to the underwriters’ right to reject any order in whole or in part. Sales of any units outside the United States may be made by affiliates of the underwriters.

Over-allotment Option

We have granted to the underwriters an option, exercisable for 45 days from the date of this prospectus, to purchase up to 3,750,000 additional units at the public offering price less the underwriting discount. The underwriters may exercise this option solely for the purpose of covering over-allotments, if any, in connection with this offering. To the extent the option is exercised, each underwriter must purchase a number of additional units approximately proportionate to that underwriter’s initial purchase commitment. Any units issued or sold under the option will be issued and sold on the same terms and conditions as the other units that are the subject